neutrophil-based

LIfT BioSciences Announces CEO Transition to Drive Next Phase of Growth with Neutrophil-based Therapies

Dr. Bo Rode Hansen, current Board member and Corporate Development Officer named Interim CEO Alex Blyth, Founder and CEO to step…

2 days ago